The Biostatistics Core (BC) provides expertise in biostatistics, clinical trials, and experimental design, as wellas supporting electronic data management for clinical research. Scientific consultation is provided by facultystatisticians who collaborate in the development of pilot projects, grant proposals and clinical protocols. TheBC statisticians help design research studies, and conduct interim and final data analyses. Core servicesinclude the development of case-report forms, databases and data entry tools to initiate clinical protocols, aswell as access to clinical research and cancer registry data repositories for retrospective research. The Coreprovides expertise and access to a variety of technologies, including modern statistical computingenvironments such as SAS, JMP, Splus, and R; specialized statistical computing tools for microarrays,genetic linkage and association studies, and pharmacokinetics; tools to implement scannable forms andelectronic data capture; web portals for data entry and study monitoring; and a centralized MS SQL-serverdatabase for clinical research. Service to the institution includes statistical review of cancer-related clinicalresearch protocols. The core is directed by Jeffrey Longmate, PhD, Director of the Department ofBiostatistics. Co-Director is Joyce Niland, PhD, Director of the Clinical Protocol Management Core. The staffof the BC includes a large part of the department, and the BC enables their participation in Cancer Centerrelatedpilot projects and proposals, which may later develop into externally funded projects. The BC isdirectly involved in Cancer Center research from the inception of a research idea to the publication of results.The BC focuses heavily on clinical research, but also supports basic and translational research, as well assupporting several other cores. The BC collaborates continually with the Biomedical Informatics Core tooperate and further develop the MIDAS clinical research database, and regularly collaborates with membersof the Clinical Protocol Management Core to implement City of Hope-conducted or coordinated clinicalprotocols. In 2005, the BC was used by 80 CC members from all Programs, and logged 204 projects,including 21 grants naming BC personnel (7 multi-project grants), and 32 clinical protocols newly openedwith BC collaboration. Annual budget for the core is $2,651,640, with 62% from the institution, 34% othersources, and 4% ($100,100) requested from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA033572-25
Application #
7714130
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-01
Project End
2012-11-30
Budget Start
2008-09-01
Budget End
2008-11-30
Support Year
25
Fiscal Year
2008
Total Cost
$71,000
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Bosworth, Alysia; Goodman, Elizabeth L; Wu, Eric et al. (2018) The Minneapolis-Manchester Quality of Life Instrument: reliability and validity of the Adult Form in cancer survivors. Qual Life Res 27:321-332
Vu, Binh Thanh; Shahin, Sophia Allaf; Croissant, Jonas et al. (2018) Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer. Sci Rep 8:8524
Ambaye, Nigus; Chen, Chih-Hong; Khanna, Swati et al. (2018) Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1? (HIF1?) in Cells. Biochemistry 57:1807-1813
Li, Sihui; Ali, Shafat; Duan, Xiaotao et al. (2018) JMJD1B Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for Development of Hematopoietic Stem and Progenitor Cells. Cell Rep 23:389-403
Pang, Ka Ming; Castanotto, Daniela; Li, Haitang et al. (2018) Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy. Nucleic Acids Res 46:e6
Yan, Wei; Wu, Xiwei; Zhou, Weiying et al. (2018) Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol 20:597-609
Bzymek, Krzysztof P; Puckett, James W; Zer, Cindy et al. (2018) Mechanically interlocked functionalization of monoclonal antibodies. Nat Commun 9:1580
Nguyen, Huong Q; Ruel, Nora; Macias, Mayra et al. (2018) Translation and Evaluation of a Lung Cancer, Palliative Care Intervention for Community Practice. J Pain Symptom Manage 56:709-718
Mendez-Dorantes, Carlos; Bhargava, Ragini; Stark, Jeremy M (2018) Repeat-mediated deletions can be induced by a chromosomal break far from a repeat, but multiple pathways suppress such rearrangements. Genes Dev 32:524-536
Zhang, Jing; He, Zhiheng; Sen, Subha et al. (2018) TCF-1 Inhibits IL-17 Gene Expression To Restrain Th17 Immunity in a Stage-Specific Manner. J Immunol 200:3397-3406

Showing the most recent 10 out of 1396 publications